Publications by authors named "Zachary B Davis"

Claim this Profile
T
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity.
Akhilesh Kumar, Bin Zhang, Andrew Baldys, Colin Fischer, Alexander Lenvik, Zachary B Davis

J Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions.
Chun Huang, Atishay Mathur, Chan-Hua Chang, Xiaoli Huang, Hsu-Yu Chen, Zachary B Davis

Res Sq· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV.
Joshua Rhein, Jeffrey G Chipman, Gregory J Beilman, Ross Cromarty, Kevin Escandón, Zachary B Davis

JCI Insight· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.
Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, Laura E Bendzick, Madison Shackelford, Zachary B Davis

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering B cells to Express Fully Customizable Antibodies with Enhanced Fc Functions.
Chun Huang, Atishay Mathur, Chan-Hua Chang, Xiaoli Huang, Hsu-Yu Chen, Zachary B Davis

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma.
Kate J Dixon, Kristin M Snyder, Melissa Khaw, Robert Hullsiek, Zachary B Davis

Front Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection.
Jeffrey S Miller, Joshua Rhein, Zachary B Davis, Sarah Cooley, David McKenna

J Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choroidal Melanoma Draining into a Retinal Vein.
Zachary B Davis, Jennifer S Zeiger, Carol L Shields

Ophthalmol Retina· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in NK cell therapy for brain tumors.
Jawad Fares, Zachary B Davis, Julian S Rechberger, Stephanie A Toll, Jonathan D Schwartz

NPJ Precis Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.
Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B Davis

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma.
Frank Cichocki, Ryan Bjordahl, Jodie P Goodridge, Sajid Mahmood, Svetlana Gaidarova, Zachary B Davis

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial.
Jeffrey S Miller, Zachary B Davis, Erika Helgeson, Cavan Reilly, Ann Thorkelson

Nat Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
Karrune V Woan, Hansol Kim, Ryan Bjordahl, Zachary B Davis, Svetlana Gaidarova

Cell Stem Cell· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy.
Frank Cichocki, Ryan Bjordahl, Svetlana Gaidarova, Sajid Mahmood, Ramzey Abujarour, Zachary B Davis

Sci Transl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.
Martin Felices, Todd R Lenvik, Zachary B Davis, Jeffrey S Miller, Daniel A Vallera

Methods Mol Biol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy.
Zachary B Davis, Daniel A Vallera, Jeffrey S Miller, Martin Felices

Semin Immunol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.
Zachary B Davis, Bharatwaj Sowrirajan, Andrew Cogswell, Jeffery P Ward, Vicente Planelles

AIDS Res Hum Retroviruses· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.
Zachary B Davis, Martin Felices, Michael R Verneris, Jeffrey S Miller

Cancer J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
Zachary B Davis, Andrew Cogswell, Hamish Scott, Amanda Mertsching, Julie Boucau

PLoS Pathog· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
Zachary B Davis, Sarah A Cooley, Frank Cichocki, Martin Felices, Rose Wangen

Biol Blood Marrow Transplant· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays.
Zachary B Davis, Jeffrey P Ward, Edward Barker

J Vis Exp· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.
Ankur H Shah, Bharatwaj Sowrirajan, Zachary B Davis, Jeffrey P Ward, Edward M Campbell

Cell Host Microbe· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis